Charity researches new brain cancer treatment

A charity is carrying out clinical trials on a new cancer treatment.

Cancer Research UK is engaged in tests on temozolomide and olaparib to find out how a combination of them could help to treat brain cancer.

Dr Nigel Blackburn, the charity's director of drug development, commented: "It's incredibly encouraging to launch this trial combining two drugs which have both been developed through work led by Cancer Research UK scientists."

He said the group hopes the new type of cancer treatment will be effective in lengthening the life expectancies of patients.

Dr Blackburn added that Cancer Research UK is investing "heavily" in coming up with new targeted treatments aimed at tackling various forms of the disease.

He stated that it is awaiting results of these various clinical trials "with great interest".

According to data from Cancer Research UK, malignant brain tumours and growths in the central nervous system were responsible for more than 3,600 fatalities in Britain during 2008.

Comment on this page »


Latest news

Chelsea and Westminster named the best place to work in the NHS for 2015

Nuffield Health opens doors of new Cambridge Hospital

Nuffield Health plans to open state-of-the-art diagnostic suite

Charity researches new brain cancer treatment
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information